Welcome to our dedicated page for Gentherm news (Ticker: THRM), a resource for investors and traders seeking the latest updates and insights on Gentherm stock.
Gentherm Inc. reports developments in thermal management and pneumatic comfort technologies for automotive and medical markets. Its Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, Valve Systems, cable systems, battery performance solutions, and automotive electronics and software systems. Its Medical business covers patient temperature management systems and related device technology.
Recurring news includes quarterly and annual results, conference participation, automotive new-business activity, shareholder voting matters, and medical-device regulatory updates. Company announcements also cover ThermAffyx™ Patient Safety System, an integrated patient warming and securement system submitted through the FDA 510(k) pathway, and communications activity around Gentherm Medical products.
Gentherm (NASDAQ: THRM) reported 2026 Q2 product revenues of $416.2 million, up 11.0% year over year, or 9.5% excluding foreign currency, led by Automotive Climate and Comfort Solutions revenue growth of 14.1%. Net income rose to $4.4 million (diluted EPS $0.14) versus $0.5 million ($0.02) a year ago, while adjusted diluted EPS increased to $0.75 from $0.54.
Gross margin was 23.2% versus 23.9% last year, pressured by higher material costs and warranty accruals. Adjusted EBITDA reached $48.8 million (11.7% margin). Cash flow from operations declined to $2.3 million from $31.7 million, mainly due to restructuring and M&A expenses. The quarter ended with net leverage of about 0.3x and liquidity of $502.3 million.
Full-year 2026 guidance was raised to product revenues of $1.55–$1.65 billion, adjusted EBITDA of $185–$200 million, and adjusted free cash flow of $85–$100 million. The Board authorized a new $400 million stock repurchase program effective July 27, 2026, replacing a prior program with $110 million remaining. Gentherm also acquired Innovative Medical Equipment, adding the ThermaZone thermal therapy device, and reported completing key sign-to-close deliverables for its planned combination with Modine Performance Technologies, which remains targeted to close by early Q4 2026.
Gentherm (NASDAQ: THRM) announced the acquisition of Innovative Medical Equipment, LLC (IME), a Cleveland-area provider of the ThermaZone thermal therapy device, on July 22, 2026. The deal is intended to strengthen Gentherm’s Medical business by expanding its portfolio with a non-opioid hot-and-cold therapy solution for pain management and recovery.
According to Gentherm, IME contributes an established technology platform and customer base that broadens Gentherm’s addressable opportunities in healthcare while aligning with its thermal and precision flow management expertise. The company expects the acquisition to support its long-term growth strategy and to create revenue synergies by leveraging expanded customer relationships across additional channels.
Gentherm (THRM) announced FDA 510(k) clearance for its patented ThermAffyx™ Patient Safety System, a Class II medical device that integrates active underbody warming, securement and pressure reduction for robotic-assisted surgery, a market the company notes includes more than 3 million procedures annually worldwide.
ThermAffyx replaces separate warming and securement solutions with a single system designed to fit into existing robotic surgical workflows, particularly procedures using the Trendelenburg position where only 17%–21% of body surface may be accessible to forced-air warming and over one-quarter of patients can be hypothermic in recovery. The device incorporates a radiolucent heating element powered by Gentherm’s proprietary Carbotex® carbon-fiber technology. Product trials at healthcare facilities are scheduled to begin in August, with revenue generation expected by Gentherm to commence in Q3 2026. According to the company, this clearance significantly expands its patient temperature management portfolio.
Gentherm (NASDAQ: THRM) will release its 2026 second quarter financial results on Thursday, July 23, 2026, followed by a conference call at 8:00 a.m. ET.
Investors can join via toll-free and international dial-in numbers or a live webcast with a one-year replay.
Gentherm (NASDAQ: THRM) was named a 2025 Supplier of the Year by General Motors at GM’s 34th annual Supplier of the Year event in Austin, Texas. This is the fourth time Gentherm has earned the award, recognizing its performance, innovation and partnership supporting GM’s global operations.
Gentherm (NASDAQ:THRM) will participate in several Q2 2026 investor conferences. Key appearances include a fireside chat at the Baird Global Consumer, Technology & Services Conference in New York on June 3, 2026, starting at 8:30 a.m. ET and lasting about 30 minutes.
A live audio webcast and 90-day replay will be available on Gentherm’s Investor Relations Events page. Management will also attend the Stifel Cross Sector 1x1 Conference on June 2, 2026, in Boston and the Wells Fargo Industrials & Materials Conference on June 9, 2026, in Chicago. Dates and participation may change; investors are directed to the Gentherm Investor Relations website for updates.
Gentherm (NASDAQ: THRM) will showcase its science-backed WellSense wellness technologies for home and office furniture at NeoCon 2026 in Chicago, including Preview Day on June 7 and exhibits June 8–10.
Demonstrations include wellness recliners, office chairs, smart desks, and medical seating built on extensive human physiology research.
Gentherm (NASDAQ:THRM) reported record Q1 2026 product revenue of $393.7M (11.3% YoY; 7.2% ex-FX), gross margin of 24.7%, net income of $4.2M, and adjusted EBITDA of $49.3M (12.5% margin). The company announced a planned combination with Modine Performance Technologies and submitted a 510(k) for ThermAffyx, expecting revenue in Q3 2026.
Full-year 2026 guidance remains: Product Revenues $1.5B–$1.6B, Adjusted EBITDA $175M–$195M, Adjusted FCF $80M–$100M. Net leverage ~0.2x and liquidity $455.5M.
Gentherm (NASDAQ: THRM) will report first‑quarter 2026 financial results on Thursday, April 23, 2026 and will host a conference call at 8:00 AM ET the same day.
Dial‑in numbers, webcast access, and replay details are provided; the telephonic replay and webcast archive will be available until May 7, 2026. Investor and media contact information is listed for follow‑up.
Gentherm (NASDAQ: THRM) announced a product launch with KUKA Home in Asia on March 19, 2026, extending Gentherm’s thermal and pneumatic comfort technologies from automotive into home furniture applications.
According to the company, the co-branded program “Enhanced Comfort by Gentherm” moves projects from development into production and underscores scalable, consumer-focused integration and speed-to-market.